Data sourced from Joe, the private fund performance platform powered by Dakota. Learn More | Request Access
Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Joe, powered by Daktoa centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is our weekly roundup of ten PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Top 5 Companies Likely to Transact
1. Molecular You
Molecular You is a Canadian health technology company specializing in personalized health assessments. By analyzing over 250 blood-based biomarkers, they provide individuals and healthcare providers with comprehensive insights into health risks, enabling proactive and informed health decisions.
- Sector: Health Care
- Last known transaction date: Series A Venture, $5M, August 2025
- Why timing suggests a near-term transaction: With its $5M Series A closing in August 2025, Molecular You will be approximately 12–18 months past that raise by mid-to-late 2026. This is a timeframe consistent with when Series A health tech and diagnostics companies typically start pursuing their next growth round. As adoption grows, biomarker and data capabilities mature, and partnerships with healthcare providers scale, the company is a reasonable candidate for follow-on funding, strategic investment, or acquisition interest.
2. Verdata
Verdata is a data intelligence platform that helps point-of-sale financing companies assess and manage merchant risk. Its platform provides underwriting insights, risk notifications, and portfolio monitoring tools that help lenders identify fraud, reduce financial exposure, and improve operational efficiency.
- Sector: B2B Risk Intelligence / Fintech
- Last known transaction date: Series A Venture, $8M, August 2025
- Why timing suggests a near-term transaction: Verdata’s $8M Series A announced in August 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A fintech and data platforms preparing for their next growth round. As customer adoption, data capabilities, and financial services partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.
3. Method AI
Method AI is a medical technology company developing an AI-powered surgical navigation platform for robotic oncology procedures. Its technology combines deep-tissue imaging and machine learning to provide physicians with real-time guidance, helping improve surgical precision and patient outcomes.
- Sector: Health Care
- Last known funding round: Series A Venture, $20M, August 2025
- Why timing suggests a near-term transaction: Method AI’s $20M Series A announced in August 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A AI companies preparing for their next growth round. As enterprise adoption, product capabilities, and strategic technology partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.
4. Embargo
Embargo is a digital loyalty and customer relationship management platform designed for restaurants and hospitality businesses. Its platform combines digital loyalty programs, customer data, and targeted marketing tools to help businesses increase customer engagement, retention, and sales across in-store and delivery channels.
- Sector: Consumer Discretionary
- Last known funding round: Seed Venture, $3.5M, August 2025
- Why timing suggests a near-term transaction: Embargo’s $3.5M seed round announced in August 2025 places the company approximately 18 months removed from its initial financing by mid to late 2026, aligning with the typical window when seed-stage companies begin preparing for their next raise. As product development, customer adoption, and commercial partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or early acquisition interest.
5. Wastelink
Wastelink is an Indian sustainability company that converts food surplus and waste into nutritious animal feed. Its platform helps food businesses reduce waste while creating value from discarded materials and supporting a more circular food supply chain.
- Sector: Consumer Staples
- Last known funding round: Series A Venture, $3M, August 2025
- Why timing suggests a near-term transaction: WasteLink’s $3M Series A announced in August 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A waste management and circular economy companies preparing for their next growth round. As collection volumes, recycling partnerships, and commercial operations expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.
Use Joe’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Joe’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
This dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
Filter by sector, geography, funding stage, last transaction date, or parent sponsor to build the list that matches your mandate.
To explore more companies likely to transact, request access to Joe.
